Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHALCON-HP: Vonoprazan for H. pylori
NCT04167670Phase 3Completed
- Sponsor
- Phathom Pharmaceuticals
- Start
- Dec 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of vonoprazan in Helicobacter pylori infection, sponsored by Phathom Pharmaceuticals. Started Dec 2019; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04167670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167670.